Evidence map›Paper›PMID 40362989›Full record

ArticlePolymers2025

A Multifunctional PEEK Composite Scaffold with Immunomodulatory, Angiogenic, and Osteogenic Properties for Enhanced Bone Regeneration.

Mengen Zhao, Han Yang, Qianwen Yang, Chao Zhang, Jie Liu, Zhaoying Wu, Lijun Wang, Wei Zhang, Bing Wang, Wenliang Liu

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mengen ZhaoShenzhen Institute for Drug Control, Shenzhen Testing Center of Medical Devices, Shenzhen 518057, China.
Han YangShenzhen Institute for Drug Control, Shenzhen Testing Center of Medical Devices, Shenzhen 518057, China.
Qianwen YangSchool of Biomedical Engineering, Shenzhen Campus, Sun Yat-sen University, Shenzhen 518107, China.
Chao ZhangSchool of Biomedical Engineering, Shenzhen Campus, Sun Yat-sen University, Shenzhen 518107, China.ORCID 0000-0001-5540-5898
Jie LiuSchool of Biomedical Engineering, Shenzhen Campus, Sun Yat-sen University, Shenzhen 518107, China.
Zhaoying WuSchool of Biomedical Engineering, Shenzhen Campus, Sun Yat-sen University, Shenzhen 518107, China.ORCID 0000-0003-2410-3752
Lijun WangShenzhen Institute for Drug Control, Shenzhen Testing Center of Medical Devices, Shenzhen 518057, China.
Wei ZhangShenzhen Institute for Drug Control, Shenzhen Testing Center of Medical Devices, Shenzhen 518057, China.
Bing WangShenzhen Institute for Drug Control, Shenzhen Testing Center of Medical Devices, Shenzhen 518057, China.
Wenliang LiuShenzhen Institute for Drug Control, Shenzhen Testing Center of Medical Devices, Shenzhen 518057, China.

Funding

The National Key Research and Development Program of China 2023YFC2412300Top 10 research projects in 2023 of Shenzhen Institute for Drug Control YNKT20230107
6 · The paper itself

Abstract

Polyetheretherketone (PEEK) is a widely used material in bone tissue engineering due to its favorable mechanical properties and radiolucency. However, its bioinert nature and lack of osteogenic activity restrict its ability to support effective bone regeneration. In this study, a novel APS-coated plasma-treated sulfonated bioactive PEEK scaffold (APS/PSBPK) was developed to overcome these limitations. The scaffold integrates strontium-doped bioactive glass (SrBG) to enhance biocompatibility and osteogenic potential, while astragalus polysaccharide (APS) was incorporated via plasma cleaning to modulate immune responses and promote vascularization. In vitro studies demonstrated that the APS/PSBPK scaffold facilitates M2 macrophage polarization, reduces pro-inflammatory cytokines, and enhances the secretion of anti-inflammatory factors. It also promotes endothelial cell migration and angiogenesis while supporting the adhesion, proliferation, and osteogenic differentiation of rBMSCs. In vivo experiments revealed that the scaffold effectively regulates the immune microenvironment, promotes vascularization, and accelerates bone regeneration. Thus, the APS/PSBPK composite scaffold serves as a multifunctional biomaterial with significant potential for applications in bone repair and regeneration by combining immunomodulation, angiogenesis, and osteogenesis.

Indexed as

angiogenesisbone regenerationimmunomodulationosteogenesispolyetheretherketone

Identifiers

PMID40362989
PMCPMC12073393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.